approval
saveLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
September 30, 2025updated 5mo ago
community read0 votes
Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalALDACTAZIDE: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalSep 30, 2025
- approvalLABETALOL HYDROCHLORIDE: LABETALOL HYDROCHLORIDE — FDA approvalSep 23, 2025
- approvalTICAGRELOR: TICAGRELOR — FDA approvalOct 28, 2025
- approvalDOXYCYCLINE HYCLATE: DOXYCYCLINE HYCLATE — FDA approvalNov 19, 2025
- approvalALDACTAZIDE: IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalNov 25, 2025
- approvalIRBESARTAN: IRBESARTAN — FDA approvalNov 25, 2025
🐶 often sniffed alongside
top 8- companyMacleods Pharma USA Inc10 co-mentions · 4 sources
- tagRecall7 co-mentions · 4 sources
- drugEuthyrox3 co-mentions · 2 sources
- drugTirosint3 co-mentions · 2 sources
- drugLevolet3 co-mentions · 2 sources
- drugErmeza3 co-mentions · 2 sources
- drugLevoxyl3 co-mentions · 2 sources
- druglevothyroxine sodium3 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that